- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Choroidal Neovascularization market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Choroidal Neovascularization market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Extreme Myopia accounting for % of the Choroidal Neovascularization global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Intravenous segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Choroidal Neovascularization include Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., and Bayer AG, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Choroidal Neovascularization market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intravenous
Intravitreal
Market segment by Application can be divided into
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
The key market players for global Choroidal Neovascularization market are listed below:
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Bausch Health
Gilead Sciences Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Choroidal Neovascularization product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Choroidal Neovascularization, with price, sales, revenue and global market share of Choroidal Neovascularization from 2019 to 2022.
Chapter 3, the Choroidal Neovascularization competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Choroidal Neovascularization breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Choroidal Neovascularization market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Choroidal Neovascularization.
Chapter 13, 14, and 15, to describe Choroidal Neovascularization sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Choroidal Neovascularization Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Choroidal Neovascularization Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Intravenous
1.2.3 Intravitreal
1.3 Market Analysis by Application
1.3.1 Overview: Global Choroidal Neovascularization Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Extreme Myopia
1.3.3 Malignant Myopic Degeneration
1.3.4 Age-Related Developments
1.4 Global Choroidal Neovascularization Market Size & Forecast
1.4.1 Global Choroidal Neovascularization Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Choroidal Neovascularization Sales in Volume (2017-2028)
1.4.3 Global Choroidal Neovascularization Price (2017-2028)
1.5 Global Choroidal Neovascularization Production Capacity Analysis
1.5.1 Global Choroidal Neovascularization Total Production Capacity (2017-2028)
1.5.2 Global Choroidal Neovascularization Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Choroidal Neovascularization Market Drivers
1.6.2 Choroidal Neovascularization Market Restraints
1.6.3 Choroidal Neovascularization Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Choroidal Neovascularization Product and Services
2.1.4 Pfizer Inc. Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 F. Hoffmann-La Roche Ltd.
2.2.1 F. Hoffmann-La Roche Ltd. Details
2.2.2 F. Hoffmann-La Roche Ltd. Major Business
2.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product and Services
2.2.4 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Choroidal Neovascularization Product and Services
2.3.4 Novartis AG Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Regeneron Pharmaceuticals Inc.
2.4.1 Regeneron Pharmaceuticals Inc. Details
2.4.2 Regeneron Pharmaceuticals Inc. Major Business
2.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product and Services
2.4.4 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bayer AG
2.5.1 Bayer AG Details
2.5.2 Bayer AG Major Business
2.5.3 Bayer AG Choroidal Neovascularization Product and Services
2.5.4 Bayer AG Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 QLT Inc.
2.6.1 QLT Inc. Details
2.6.2 QLT Inc. Major Business
2.6.3 QLT Inc. Choroidal Neovascularization Product and Services
2.6.4 QLT Inc. Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sanwa Kagaku Kenkyusho Co. Ltd.
2.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Details
2.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Major Business
2.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product and Services
2.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Promedior Inc.
2.8.1 Promedior Inc. Details
2.8.2 Promedior Inc. Major Business
2.8.3 Promedior Inc. Choroidal Neovascularization Product and Services
2.8.4 Promedior Inc. Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bausch Health
2.9.1 Bausch Health Details
2.9.2 Bausch Health Major Business
2.9.3 Bausch Health Choroidal Neovascularization Product and Services
2.9.4 Bausch Health Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Gilead Sciences Inc
2.10.1 Gilead Sciences Inc Details
2.10.2 Gilead Sciences Inc Major Business
2.10.3 Gilead Sciences Inc Choroidal Neovascularization Product and Services
2.10.4 Gilead Sciences Inc Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Choroidal Neovascularization Breakdown Data by Manufacturer
3.1 Global Choroidal Neovascularization Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Choroidal Neovascularization Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Choroidal Neovascularization
3.4 Market Concentration Rate
3.4.1 Top 3 Choroidal Neovascularization Manufacturer Market Share in 2021
3.4.2 Top 6 Choroidal Neovascularization Manufacturer Market Share in 2021
3.5 Global Choroidal Neovascularization Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Choroidal Neovascularization Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Choroidal Neovascularization Market Size by Region
4.1.1 Global Choroidal Neovascularization Sales in Volume by Region (2017-2028)
4.1.2 Global Choroidal Neovascularization Revenue by Region (2017-2028)
4.2 North America Choroidal Neovascularization Revenue (2017-2028)
4.3 Europe Choroidal Neovascularization Revenue (2017-2028)
4.4 Asia-Pacific Choroidal Neovascularization Revenue (2017-2028)
4.5 South America Choroidal Neovascularization Revenue (2017-2028)
4.6 Middle East and Africa Choroidal Neovascularization Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Choroidal Neovascularization Sales in Volume by Type (2017-2028)
5.2 Global Choroidal Neovascularization Revenue by Type (2017-2028)
5.3 Global Choroidal Neovascularization Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Choroidal Neovascularization Sales in Volume by Application (2017-2028)
6.2 Global Choroidal Neovascularization Revenue by Application (2017-2028)
6.3 Global Choroidal Neovascularization Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Choroidal Neovascularization Sales by Type (2017-2028)
7.2 North America Choroidal Neovascularization Sales by Application (2017-2028)
7.3 North America Choroidal Neovascularization Market Size by Country
7.3.1 North America Choroidal Neovascularization Sales in Volume by Country (2017-2028)
7.3.2 North America Choroidal Neovascularization Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Choroidal Neovascularization Sales by Type (2017-2028)
8.2 Europe Choroidal Neovascularization Sales by Application (2017-2028)
8.3 Europe Choroidal Neovascularization Market Size by Country
8.3.1 Europe Choroidal Neovascularization Sales in Volume by Country (2017-2028)
8.3.2 Europe Choroidal Neovascularization Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Choroidal Neovascularization Sales by Type (2017-2028)
9.2 Asia-Pacific Choroidal Neovascularization Sales by Application (2017-2028)
9.3 Asia-Pacific Choroidal Neovascularization Market Size by Region
9.3.1 Asia-Pacific Choroidal Neovascularization Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Choroidal Neovascularization Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Choroidal Neovascularization Sales by Type (2017-2028)
10.2 South America Choroidal Neovascularization Sales by Application (2017-2028)
10.3 South America Choroidal Neovascularization Market Size by Country
10.3.1 South America Choroidal Neovascularization Sales in Volume by Country (2017-2028)
10.3.2 South America Choroidal Neovascularization Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Choroidal Neovascularization Sales by Type (2017-2028)
11.2 Middle East & Africa Choroidal Neovascularization Sales by Application (2017-2028)
11.3 Middle East & Africa Choroidal Neovascularization Market Size by Country
11.3.1 Middle East & Africa Choroidal Neovascularization Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Choroidal Neovascularization Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Choroidal Neovascularization and Key Manufacturers
12.2 Manufacturing Costs Percentage of Choroidal Neovascularization
12.3 Choroidal Neovascularization Production Process
12.4 Choroidal Neovascularization Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Choroidal Neovascularization Typical Distributors
13.3 Choroidal Neovascularization Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Choroidal Neovascularization Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Choroidal Neovascularization Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Choroidal Neovascularization Product and Services
Table 6. Pfizer Inc. Choroidal Neovascularization Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 8. F. Hoffmann-La Roche Ltd. Major Business
Table 9. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product and Services
Table 10. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 12. Novartis AG Major Business
Table 13. Novartis AG Choroidal Neovascularization Product and Services
Table 14. Novartis AG Choroidal Neovascularization Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Regeneron Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Regeneron Pharmaceuticals Inc. Major Business
Table 17. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product and Services
Table 18. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 20. Bayer AG Major Business
Table 21. Bayer AG Choroidal Neovascularization Product and Services
Table 22. Bayer AG Choroidal Neovascularization Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. QLT Inc. Basic Information, Manufacturing Base and Competitors
Table 24. QLT Inc. Major Business
Table 25. QLT Inc. Choroidal Neovascularization Product and Services
Table 26. QLT Inc. Choroidal Neovascularization Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sanwa Kagaku Kenkyusho Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table 28. Sanwa Kagaku Kenkyusho Co. Ltd. Major Business
Table 29. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product and Services
Table 30. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Promedior Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Promedior Inc. Major Business
Table 33. Promedior Inc. Choroidal Neovascularization Product and Services
Table 34. Promedior Inc. Choroidal Neovascularization Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 36. Bausch Health Major Business
Table 37. Bausch Health Choroidal Neovascularization Product and Services
Table 38. Bausch Health Choroidal Neovascularization Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Gilead Sciences Inc Basic Information, Manufacturing Base and Competitors
Table 40. Gilead Sciences Inc Major Business
Table 41. Gilead Sciences Inc Choroidal Neovascularization Product and Services
Table 42. Gilead Sciences Inc Choroidal Neovascularization Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Choroidal Neovascularization Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Choroidal Neovascularization Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Choroidal Neovascularization, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Choroidal Neovascularization Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Choroidal Neovascularization Production Site of Key Manufacturer
Table 48. Choroidal Neovascularization New Entrant and Capacity Expansion Plans
Table 49. Choroidal Neovascularization Mergers & Acquisitions in the Past Five Years
Table 50. Global Choroidal Neovascularization Sales by Region (2017-2022) & (K Units)
Table 51. Global Choroidal Neovascularization Sales by Region (2023-2028) & (K Units)
Table 52. Global Choroidal Neovascularization Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Choroidal Neovascularization Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Choroidal Neovascularization Sales by Type (2017-2022) & (K Units)
Table 55. Global Choroidal Neovascularization Sales by Type (2023-2028) & (K Units)
Table 56. Global Choroidal Neovascularization Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Choroidal Neovascularization Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Choroidal Neovascularization Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Choroidal Neovascularization Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Choroidal Neovascularization Sales by Application (2017-2022) & (K Units)
Table 61. Global Choroidal Neovascularization Sales by Application (2023-2028) & (K Units)
Table 62. Global Choroidal Neovascularization Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Choroidal Neovascularization Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Choroidal Neovascularization Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Choroidal Neovascularization Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Choroidal Neovascularization Sales by Country (2017-2022) & (K Units)
Table 67. North America Choroidal Neovascularization Sales by Country (2023-2028) & (K Units)
Table 68. North America Choroidal Neovascularization Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Choroidal Neovascularization Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Choroidal Neovascularization Sales by Type (2017-2022) & (K Units)
Table 71. North America Choroidal Neovascularization Sales by Type (2023-2028) & (K Units)
Table 72. North America Choroidal Neovascularization Sales by Application (2017-2022) & (K Units)
Table 73. North America Choroidal Neovascularization Sales by Application (2023-2028) & (K Units)
Table 74. Europe Choroidal Neovascularization Sales by Country (2017-2022) & (K Units)
Table 75. Europe Choroidal Neovascularization Sales by Country (2023-2028) & (K Units)
Table 76. Europe Choroidal Neovascularization Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Choroidal Neovascularization Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Choroidal Neovascularization Sales by Type (2017-2022) & (K Units)
Table 79. Europe Choroidal Neovascularization Sales by Type (2023-2028) & (K Units)
Table 80. Europe Choroidal Neovascularization Sales by Application (2017-2022) & (K Units)
Table 81. Europe Choroidal Neovascularization Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Choroidal Neovascularization Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Choroidal Neovascularization Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Choroidal Neovascularization Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Choroidal Neovascularization Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Choroidal Neovascularization Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Choroidal Neovascularization Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Choroidal Neovascularization Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Choroidal Neovascularization Sales by Application (2023-2028) & (K Units)
Table 90. South America Choroidal Neovascularization Sales by Country (2017-2022) & (K Units)
Table 91. South America Choroidal Neovascularization Sales by Country (2023-2028) & (K Units)
Table 92. South America Choroidal Neovascularization Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Choroidal Neovascularization Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Choroidal Neovascularization Sales by Type (2017-2022) & (K Units)
Table 95. South America Choroidal Neovascularization Sales by Type (2023-2028) & (K Units)
Table 96. South America Choroidal Neovascularization Sales by Application (2017-2022) & (K Units)
Table 97. South America Choroidal Neovascularization Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Choroidal Neovascularization Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Choroidal Neovascularization Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Choroidal Neovascularization Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Choroidal Neovascularization Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Choroidal Neovascularization Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Choroidal Neovascularization Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Choroidal Neovascularization Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Choroidal Neovascularization Sales by Application (2023-2028) & (K Units)
Table 106. Choroidal Neovascularization Raw Material
Table 107. Key Manufacturers of Choroidal Neovascularization Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Choroidal Neovascularization Typical Distributors
Table 111. Choroidal Neovascularization Typical Customers
List of Figures
Figure 1. Choroidal Neovascularization Picture
Figure 2. Global Choroidal Neovascularization Revenue Market Share by Type in 2021
Figure 3. Intravenous
Figure 4. Intravitreal
Figure 5. Global Choroidal Neovascularization Revenue Market Share by Application in 2021
Figure 6. Extreme Myopia
Figure 7. Malignant Myopic Degeneration
Figure 8. Age-Related Developments
Figure 9. Global Choroidal Neovascularization Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Choroidal Neovascularization Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Choroidal Neovascularization Sales (2017-2028) & (K Units)
Figure 12. Global Choroidal Neovascularization Price (2017-2028) & (USD/Unit)
Figure 13. Global Choroidal Neovascularization Production Capacity (2017-2028) & (K Units)
Figure 14. Global Choroidal Neovascularization Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Choroidal Neovascularization Market Drivers
Figure 16. Choroidal Neovascularization Market Restraints
Figure 17. Choroidal Neovascularization Market Trends
Figure 18. Global Choroidal Neovascularization Sales Market Share by Manufacturer in 2021
Figure 19. Global Choroidal Neovascularization Revenue Market Share by Manufacturer in 2021
Figure 20. Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Choroidal Neovascularization Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Choroidal Neovascularization Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Choroidal Neovascularization Sales Market Share by Region (2017-2028)
Figure 24. Global Choroidal Neovascularization Revenue Market Share by Region (2017-2028)
Figure 25. North America Choroidal Neovascularization Revenue (2017-2028) & (USD Million)
Figure 26. Europe Choroidal Neovascularization Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Choroidal Neovascularization Revenue (2017-2028) & (USD Million)
Figure 28. South America Choroidal Neovascularization Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Choroidal Neovascularization Revenue (2017-2028) & (USD Million)
Figure 30. Global Choroidal Neovascularization Sales Market Share by Type (2017-2028)
Figure 31. Global Choroidal Neovascularization Revenue Market Share by Type (2017-2028)
Figure 32. Global Choroidal Neovascularization Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Choroidal Neovascularization Sales Market Share by Application (2017-2028)
Figure 34. Global Choroidal Neovascularization Revenue Market Share by Application (2017-2028)
Figure 35. Global Choroidal Neovascularization Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Choroidal Neovascularization Sales Market Share by Type (2017-2028)
Figure 37. North America Choroidal Neovascularization Sales Market Share by Application (2017-2028)
Figure 38. North America Choroidal Neovascularization Sales Market Share by Country (2017-2028)
Figure 39. North America Choroidal Neovascularization Revenue Market Share by Country (2017-2028)
Figure 40. United States Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Choroidal Neovascularization Sales Market Share by Type (2017-2028)
Figure 44. Europe Choroidal Neovascularization Sales Market Share by Application (2017-2028)
Figure 45. Europe Choroidal Neovascularization Sales Market Share by Country (2017-2028)
Figure 46. Europe Choroidal Neovascularization Revenue Market Share by Country (2017-2028)
Figure 47. Germany Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Choroidal Neovascularization Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Choroidal Neovascularization Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Choroidal Neovascularization Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Choroidal Neovascularization Revenue Market Share by Region (2017-2028)
Figure 56. China Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Choroidal Neovascularization Sales Market Share by Type (2017-2028)
Figure 63. South America Choroidal Neovascularization Sales Market Share by Application (2017-2028)
Figure 64. South America Choroidal Neovascularization Sales Market Share by Country (2017-2028)
Figure 65. South America Choroidal Neovascularization Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Choroidal Neovascularization Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Choroidal Neovascularization Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Choroidal Neovascularization Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Choroidal Neovascularization Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Choroidal Neovascularization Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Choroidal Neovascularization in 2021
Figure 77. Manufacturing Process Analysis of Choroidal Neovascularization
Figure 78. Choroidal Neovascularization Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
